Sign inJoin waitlistJoin the waitlist

Andrew Blakely

Program Director, Surgical Oncology Research Fellowship · Clinical Center at the National Institutes of Health

Credentials: · · · ·

History

Surgical Oncology Research Fellowship · Clinical Center at the National Institutes of Health
Present
Surgical Oncology Fellowship · Clinical Center at the National Institutes of Health
Present
Clinical Center at the National Institutes of Health Fellowship
Present

Complex General Surgical Oncology
City of Hope National Medical Center
2015–2017
General Surgery
Brown University
2010–2015
Drexel University
2006–2010

Research

Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations
Review · Journal of Thoracic Oncology · 2022 · 83 citations
Germline CDH1 Variants and Lifetime Cancer Risk
JAMA · 2024 · 58 citations
Bio-Pick, Place, and Perfuse: A New Instrument for Three-Dimensional Tissue Engineering
Tissue engineering. Part C · 2015 · First of 4 authors · 51 citations

Jeremy Davis
44 papers
Jonathan Hernandez
43 papers
Amber Gallanis
12 papers · 12 as a fellow
Byrne Lee
12 papers
Mustafa Raoof
11 papers · 1 as a fellow
TH
Theo Heller
11 papers
Alyssa Eade
10 papers · 10 as a resident
Leila Sarvestani
10 papers · 10 as a fellow
Shruthi Perati
10 papers · 10 as a resident
Thomas Miner
10 papers
Tracey Pu
10 papers · 10 as a resident
Carolina Larrain
9 papers · 9 as a resident

Grants

Surgical Oncology Program Training Program
National Cancer Institute · ZIE
Contact PI · $17.3M · Division of Basic Sciences - Nci

Clinical trials

Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2023–2025
Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2022–2025
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Principal investigator · Recruiting · Phase 1
National Cancer Institute (NCI)
2021–2034
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
Principal investigator · Recruiting
National Cancer Institute (NCI)
2020–2040